London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study ...

GSK (GSK) announced “statistically significant and clinically meaningful” overall survival results from a planned interim analysis of the ...

【葛兰素史克的液体脑膜炎疫苗获欧盟批准】葛兰素史克(GSK)的液体脑膜炎疫苗Menveo已获得欧盟委员会的批准，可在欧盟销售。这家英国制药公司周三表示，这种全液体疫苗有助于简化针对侵袭性脑膜炎球菌病(IMD)的疫苗接种流程，因为它为医疗健康提供者提供了一种无需在使用前进行复溶的选择。

In November 2024, the European Commission approved GSK's single-vial, fully liquid Menveo vaccine (MenACWY). "Muna-GSK ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...

GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new ... Subscribe now to see this Premium News article from Alliance News ...

Previously head of GSK’s consumer health division, Walmsley joined the company in 2010 after spending 17 years at L’Oreal. Witty has been in charge of GSK since 2008 and is paid nearly £1.1 ...

GSK announced today that the European Commission (EC) has granted approval for a new single-vial, fully liquid presentation of its Menveo meningococcal vaccine. The approval provides a simplified, ...